Arformoterol Tartrate Inhalation Solution
Product Images NDC 70436-151

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate Inhalation (NDC 70436-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 01)

Chemical structure of Arformoterol Tartrate, the active ingredient in Arformoterol Tartrate Inhalation solution. The image depicts the molecular arrangement of the drug compound used for respiratory inhalation therapy.*

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 02)

This is a line graph showing mean change from baseline FEV1 (L) on the vertical axis over hours postdose on the horizontal axis (0 to 12 hours). Two lines compare placebo and 15 mcg arformoterol tartrate inhalation solution BID in patients. The arformoterol line shows a significantly greater increase in FEV1 compared to placebo over the 12-hour period.*

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 04)

A line graph displaying the mean change from baseline FEV1 (L) on the y-axis over hours postdose on the x-axis, comparing placebo and 15 mcg arformoterol tartrate inhalation solution BID. The graph shows an increase in FEV1 for the arformoterol group, peaking early and gradually declining, while the placebo group remains near baseline or below throughout 12 hours postdose.*

FDA Label Image

Carton Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 06)

Packaging label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by Slate Run Pharmaceuticals. The label indicates 60 sterile unit-dose vials per carton, intended for oral inhalation only. Storage instructions specify refrigeration or room temperature for up to 6 weeks. The label includes manufacturer and NDC 70436-151-58 details.*

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 1)

A black and white instructional illustration showing a hand holding a small inhalation device or vial and twisting off the top cap, indicated by an arrow curving clockwise. The image demonstrates how to open the inhalation solution container.*

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 2)

Illustration showing a hand holding a marker or pen poised above a container labeled 'RESERVOIR,' demonstrating marking or writing on the reservoir component, likely part of a medical device or inhalation system for Arformoterol Tartrate Inhalation solution.*

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 3)

An instructional diagram illustrating the mouthpiece component of an inhalation device, showing its attachment to the main inhaler chamber with a side opening and a bottom tube connection.*

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 4)

An instructional illustration showing the proper placement of a face mask on a person's face, likely related to the use of a respiratory inhalation device. The image depicts a person wearing a mask connected to an inhaler or nebulizer.*

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 5)

An instructional illustration showing the connection of tubing to a compressor device. The diagram highlights the compressor unit with a knob and a display, and the tubing being attached to it, indicating part of the inhalation setup process.*

FDA Label Image

Image (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 6)

An illustration showing a person using a respiratory inhalation device, with the mouthpiece placed near the lips for inhalation. The image depicts hand positioning and mouth placement for inhaling a solution medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.